Searched for
INNOVATION IN PHARMA
Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...- Germany's Bayer to invest $2.2 billion in US pharma siteBayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follo...
- Nifty valuations near post-Covid lows. Alchemy Capital’s Alok Agarwal explains what investors should buy nowNifty valuations have reset sharply from 2024 levels and are now near post-Covid lows, says Alchemy Capital’s Alok Agarwal. He sees the nex...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- FIIs dump telecom for 8th straight month, outflows cross Rs 32,000 crore. Are stocks set for rebound?Foreign portfolio investors have dumped Indian telecom stocks for the eighth consecutive month, pulling out over Rs 32,000 crore in CY26. H...
- Inside the deal engine room: VCs and PEs make the case for ERP as a governance variableAt an NTT DATA Business Solutions Pvt. Ltd. India roundtable, a cohort of leading VCs and PE investors argued that the maturity of a compan...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- New indicator for New India: 25 stocks whose numbers can reveal what is in store for the economy and the stock marketFor decades, there was a familiar way to understand the Indian consumer. Economists waited for GDP, industrial production, inflation, credi...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- ET Startup Awards 2026: Theranautilus’ nanorobots will be ready for human trials by year-endTheranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...
- Quant Mid Cap Fund exits ICICI Bank, 2 others and adds 5 stocks in AugustQuant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- India’s semiconductor push will need a new approach to water management: CN WaterIndia’s semiconductor push is creating a new demand for smarter, more reliable water infrastructure. CN Water’s Shoeb Kurawadwala on locali...
- MSD inaugurates 2.5 lakh sq ft tech centre in HyderabadGlobal biopharmaceutical company MSD has opened a new technology centre in Hyderabad. This facility will enhance the company's digital, dat...
Load More
